Interleukin-1 triggers the down-regulation of several hepatic cytochrome P450 gene products, but the cellular signaling pathways involved are not known. We have examined the role of sphingomyelin hydrolysis to ceramide in the suppression of CYP2C11, a major constitutive form of cytochrome P450, by interleukin-1. Treatment of rat hepatocytes cultured on matrigel with interleukin-1 caused a rapid turnover of sphingomyelin and an increase in cellular ceramide, with no change in cellular phosphatidylcholine. The ceramide was composed mainly of a D-erythro-sphingosine backbone, suggesting that it was derived from sphingolipid hydrolysis rather than from increased de novo synthesis. Treatment of the cells with either N-acetyl-D-erythro-sphingosine (C 2 -ceramide) or bacterial sphingomyelinase suppressed the expression of CYP2C11 and induced the expression of the interleukin-1-responsive ␣ 1 -acid glycoprotein mRNA. In contrast, the acute-phase gene -fibrinogen, which is induced by interleukin-6 but not by interleukin-1, did not respond to C 2 -ceramide. N-Acetyl-D-erythro-sphinganine mimicked the effect of C 2 -ceramide on CYP2C11, but not on ␣ 1 -acid glycoprotein expression. These results are consistent with a role for ceramide or a related sphingolipid in mediating the down-regulation of CYP2C11, the induction of ␣ 1 -acid glycoprotein, and perhaps other cellular effects of interleukin-1 in hepatocytes.Stimulation of the immune system during an infection or inflammation results in an impairment of hepatic drug metabolism and a decrease in the hepatic content of cytochrome P450, the family of enzymes that are responsible for the metabolism of many drugs and chemical toxins (2-4). The decrease in drug clearance can result in adverse reactions to normal doses of clinically important drugs, such as theophylline (5), that have low therapeutic indices.At least part of the decrease in P450 1 -catalyzed metabolism in response to inflammatory stimuli such as bacterial endotoxin is due to the down-regulation of multiple P450 gene products (6, 7), which appear to be manifested mainly at the transcriptional level (8). The down-regulation of P450 genes is accompanied by a well characterized induction of hepatic plasma proteins (such as fibrinogen and ␣ 1 -acid glycoprotein (9), which are called the "positive acute-phase proteins") and a decreased synthesis of "negative acute-phase proteins" (such as albumin (9)). Cytokines, together with glucocorticoids, are the major humoral mediators of the acute phase of host defense after injury and infection (9). Numerous in vivo and in vitro studies have shown that IL-1 plays a key role in inducing many of the acute-phase proteins at both transcriptional and post-transcriptional levels (9), whereas others are induced mainly by the action of interleukin-6 (9). A role for IL-1 in the down-regulation of P450 genes has been inferred from several studies in which injection of IL-1 in vivo reduced the expression of various P450 gene products (10 -13). However, until now, studies on the mec...